ImageneBio Total Assets from 2010 to 2026
| IMA Stock | 7.07 0.22 3.02% |
Total Assets | First Reported 2019-12-31 | Previous Quarter 126.2 M | Current Value 160.9 M | Quarterly Volatility 58.3 M |
Check ImageneBio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImageneBio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Selling General Administrative of 14.6 M or Total Revenue of 3.8 M, as well as many indicators such as Price To Sales Ratio of 296, Dividend Yield of 0.0 or PTB Ratio of 7.13. ImageneBio financial statements analysis is a perfect complement when working with ImageneBio Valuation or Volatility modules.
ImageneBio | Total Assets | Build AI portfolio with ImageneBio Stock |
Analyzing ImageneBio's Total Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Total Assets has evolved provides context for assessing ImageneBio's current valuation and future prospects.
Latest ImageneBio's Total Assets Growth Pattern
Below is the plot of the Total Assets of ImageneBio over the last few years. Total assets refers to the total amount of ImageneBio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ImageneBio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. ImageneBio's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ImageneBio's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 141.51 M | 10 Years Trend |
|
Total Assets |
| Timeline |
ImageneBio Total Assets Regression Statistics
| Arithmetic Mean | 89,329,772 | |
| Geometric Mean | 54,249,623 | |
| Coefficient Of Variation | 90.51 | |
| Mean Deviation | 73,087,026 | |
| Median | 20,676,000 | |
| Standard Deviation | 80,856,098 | |
| Sample Variance | 6537.7T | |
| Range | 227.2M | |
| R-Value | 0.82 | |
| Mean Square Error | 2291.2T | |
| R-Squared | 0.67 | |
| Significance | 0.000057 | |
| Slope | 13,120,430 | |
| Total Sum of Squares | 104603.3T |
ImageneBio Total Assets History
Other Fundumenentals of ImageneBio
ImageneBio Total Assets component correlations
Click cells to compare fundamentals
About ImageneBio Financial Statements
ImageneBio stakeholders use historical fundamental indicators, such as ImageneBio's Total Assets, to determine how well the company is positioned to perform in the future. Although ImageneBio investors may analyze each financial statement separately, they are all interrelated. For example, changes in ImageneBio's assets and liabilities are reflected in the revenues and expenses on ImageneBio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ImageneBio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Assets | 162.7 M | 161.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ImageneBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ImageneBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Imagenebio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Imagenebio Stock:Check out the analysis of ImageneBio Correlation against competitors. For information on how to trade ImageneBio Stock refer to our How to Trade ImageneBio Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. Market participants price ImageneBio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ImageneBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
ImageneBio's market price often diverges from its book value, the accounting figure shown on ImageneBio's balance sheet. Smart investors calculate ImageneBio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ImageneBio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.